The longstanding CEO, Dr. Colin Goldschmidt, has decided to hang it up after more than three decades at the helm and will formally retire at the company's AGM in November.
His overall stewardship has been a success, despite the struggles in more recent years.
Probably a good time for a successor. The chosen one Dr. Jim Newcombe, is also an insider.